Catalyst Pharmaceuticals, Inc.
CPRX
$21.02
$0.150.72%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 129.50% | 130.18% | -41.02% | -34.49% | -14.05% |
| Total Depreciation and Amortization | 14.88% | 53.82% | 123.87% | 357.54% | 2,553.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -90.56% | -86.56% | 617.00% | 428.07% | 325.74% |
| Change in Net Operating Assets | 182.83% | 199.59% | 120.24% | -519.65% | -371.86% |
| Cash from Operations | 67.00% | 75.41% | 58.48% | 36.62% | 23.74% |
| Capital Expenditure | 99.72% | 77.49% | 78.90% | 78.91% | -1,879.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 97.60% | -1,062.48% | -593.70% | -593.70% |
| Cash from Investing | 99.81% | 84.80% | 19.17% | 14.25% | -3,287.12% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5,434.20% | 2,715.55% | 1,503.37% | 1,364.01% | -70.82% |
| Repurchase of Common Stock | 31.98% | 11.10% | 11.10% | 86.00% | 86.24% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.07% | -4.00% | -519.48% | -861.79% | -1,616.40% |
| Cash from Financing | 1,395.62% | 1,807.61% | 2,029.20% | 3,731.56% | -740.91% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 336.33% | 337.88% | 712.94% | 638.30% | -226.63% |
